基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GRFS 基立福

休市中 04-17 16:00:00 EDT

7.08

+0.05

+0.71%

盘后7.08

+0.000.00%

16:02 EDT

最高7.15	最低6.97	成交量50.01万
今开7.03	昨收7.03	日振幅2.56%
总市值48.17亿	流通市值39.72亿	总股本6.80亿
成交额352.03万	换手率0.09%	流通股本5.61亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GRFS","market":"US","secType":"STK","nameCN":"基立福","latestPrice":7.08,"timestamp":1744920000000,"preClose":7.03,"halted":0,"volume":500119,"hourTrading":{"tag":"盘后","latestPrice":7.08,"preClose":7.08,"latestTime":"16:02 EDT","volume":5072,"amount":35909.76,"timestamp":1744920121849},"delay":0,"floatShares":560961720,"shares":680409104,"eps":0.238119,"marketStatus":"休市中","change":0.05,"latestTime":"04-17 16:00:00 EDT","open":7.03,"high":7.15,"low":6.97,"amount":3520317.886299,"amplitude":0.025605,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.238119,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":1,"adrRate":1,"listingDate":1320120000000,"exchange":"NASDAQ","adjPreClose":7.03,"dividendRate":0.056369,"preHourTrading":{"tag":"盘前","latestPrice":7.04,"preClose":7.03,"latestTime":"09:29 EDT","volume":1402,"amount":9834.080565600001,"timestamp":1744896599907},"postHourTrading":{"tag":"盘后","latestPrice":7.08,"preClose":7.08,"latestTime":"16:02 EDT","volume":5072,"amount":35909.76,"timestamp":1744920121849},"volumeRatio":0.6078920622097866,"impliedVol":0.4603,"impliedVolPercentile":0.3586},"requestUrl":"/m/hq/s/GRFS","defaultTab":"news","newsList":[{"id":"2518208390","title":"基立福盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518208390?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:55","pubTimestamp":1741625733,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时55分，基立福股票出现异动，股价急速跳水5.16%。截至发稿，该股报8.00美元/股，成交量99.304万股，换手率0.15%，振幅2.95%。基立福股票所在的制药行业中，整体跌幅为1.82%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100553498a2c674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100553498a2c674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2517948832","title":"基立福盘中异动 早盘急速拉升5.02%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517948832?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185081,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，基立福股票出现异动，股价急速上涨5.02%。截至发稿，该股报8.69美元/股，成交量4.9073万股，换手率0.01%，振幅0.12%。基立福股票所在的制药行业中，整体跌幅为0.20%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223122abe9b081&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223122abe9b081&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2514936389","title":"基立福在西班牙马德里交易所涨幅扩大至12%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514936389","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514936389?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:11","pubTimestamp":1740669067,"startTime":"0","endTime":"0","summary":"基立福在西班牙马德里交易所涨幅扩大至12%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27231148438873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2514386458","title":"基立福盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514386458?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:03","pubTimestamp":1740668598,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时03分，基立福股票出现异动，股价大幅拉升5.16%。截至发稿，该股报8.35美元/股，成交量88.3213万股，换手率0.13%，振幅4.91%。基立福股票所在的制药行业中，整体涨幅为0.79%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272303189632b81e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272303189632b81e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2514286863","title":"基立福盘中异动 临近午盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514286863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514286863?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:54","pubTimestamp":1740588887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时54分，基立福股票出现异动，股价大幅上涨5.42%。截至发稿，该股报7.78美元/股，成交量76.5194万股，换手率0.11%，振幅6.91%。基立福股票所在的制药行业中，整体涨幅为0.31%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270054479893c5e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270054479893c5e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2514043656","title":"基立福盘中异动 下午盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514043656?lang=zh_cn&edition=full","pubTime":"2025-02-26 03:23","pubTimestamp":1740511434,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日03时23分，基立福股票出现异动，股价大幅跳水5.11%。截至发稿，该股报7.05美元/股，成交量105.823万股，换手率0.16%，振幅8.34%。基立福股票所在的制药行业中，整体涨幅为1.36%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032354abdcc195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032354abdcc195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2511863524","title":"基立福盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511863524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511863524?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:09","pubTimestamp":1739459395,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时09分，基立福股票出现异动，股价急速上涨5.06%。截至发稿，该股报7.37美元/股，成交量19.5011万股，换手率0.03%，振幅2.50%。基立福股票所在的制药行业中，整体涨幅为0.51%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230956abcdb976&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230956abcdb976&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2505112720","title":"基立福盘中异动 早盘大幅下跌5.27%报7.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505112720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505112720?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642696,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，基立福股票出现异动，股价大幅下跌5.27%。截至发稿，该股报7.01美元/股，成交量8.968万股，换手率0.01%，振幅0.27%。基立福股票所在的制药行业中，整体跌幅为0.27%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223136a22d0952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223136a22d0952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2505725593","title":"上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505725593","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505725593?lang=zh_cn&edition=full","pubTime":"2025-01-22 19:53","pubTimestamp":1737546826,"startTime":"0","endTime":"0","summary":"与2024年度的实际发生情况相比，基立福全球的交易实际发生金额为4.87亿美元，较预计金额的5.62亿美元有65.73%的差异，主要因市场变化和供货商的实际放行情况影响了采购量。GDS的交易实际发生金额为0.13亿美元，低于预计的0.2亿美元，差异为1.72%。对于海尔生物的交易，2024年实际发生金额为1612万元人民币，远低于预计的金额。文章来源：财中社上海莱士预计2025年度与基立福下属公司的交易额为5.2亿美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122220550a22bab64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122220550a22bab64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2503622235","title":"基立福盘中异动 大幅上涨5.10%报7.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503622235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503622235?lang=zh_cn&edition=full","pubTime":"2025-01-16 01:06","pubTimestamp":1736960792,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日01时06分，基立福股票出现异动，股价快速拉升5.10%。截至发稿，该股报7.42美元/股，成交量52.3064万股，换手率0.08%，振幅3.40%。基立福股票所在的制药行业中，整体涨幅为0.57%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011601063298675f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011601063298675f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2502860408","title":"基立福盘中异动 股价大跌5.00%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502860408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502860408?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:08","pubTimestamp":1736521709,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时08分，基立福股票出现异动，股价快速跳水5.00%。截至发稿，该股报7.22美元/股，成交量14.6785万股，换手率0.02%，振幅1.58%。基立福股票所在的制药行业中，整体涨幅为0.24%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230829a21d1735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230829a21d1735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2494839382","title":"基立福盘中异动 早盘股价大跌5.10%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494839382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494839382?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:22","pubTimestamp":1735312922,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时22分，基立福股票出现波动，股价快速跳水5.10%。截至发稿，该股报7.45美元/股，成交量25.493万股，换手率0.04%，振幅2.17%。基立福股票所在的制药行业中，整体跌幅为0.38%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272322039851df63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272322039851df63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2492110089","title":"基立福盘中异动 下午盘股价大涨5.05%报7.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492110089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492110089?lang=zh_cn&edition=full","pubTime":"2024-12-20 02:38","pubTimestamp":1734633494,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日02时38分，基立福股票出现异动，股价快速拉升5.05%。截至发稿，该股报7.81美元/股，成交量54.4987万股，换手率0.08%，振幅4.84%。基立福股票所在的制药行业中，整体跌幅为0.76%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220023814a1fbb85a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220023814a1fbb85a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2492515320","title":"基立福盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492515320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492515320?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:32","pubTimestamp":1734550326,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时32分，基立福股票出现异动，股价急速跳水5.08%。截至发稿，该股报7.64美元/股，成交量46.8777万股，换手率0.07%，振幅4.22%。基立福股票所在的制药行业中，整体跌幅为0.79%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219033207a1f93ea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219033207a1f93ea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2492051993","title":"基立福盘中异动 大幅上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492051993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492051993?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:19","pubTimestamp":1734455970,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时19分，基立福股票出现异动，股价大幅上涨5.18%。截至发稿，该股报8.02美元/股，成交量49.4408万股，换手率0.07%，振幅4.59%。基立福股票所在的制药行业中，整体涨幅为0.73%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801193095ea34da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801193095ea34da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2490891149","title":"基立福盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490891149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490891149?lang=zh_cn&edition=full","pubTime":"2024-12-12 02:51","pubTimestamp":1733943082,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日02时51分，基立福股票出现波动，股价急速上涨5.00%。截至发稿，该股报7.56美元/股，成交量56.5658万股，换手率0.08%，振幅5.76%。基立福股票所在的制药行业中，整体跌幅为0.35%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121202512295e9022e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121202512295e9022e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2487155047","title":"基立福盘中异动 早盘股价大跌12.52%报7.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487155047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2487155047?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:31","pubTimestamp":1732890662,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时31分，基立福股票出现异动，股价急速下跌12.52%。截至发稿，该股报7.06美元/股，成交量41.4839万股，换手率0.06%，振幅0.25%。基立福股票所在的制药行业中，整体涨幅为0.09%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。11 月 19 日，Brookfield曾提出一项估值64.5亿欧元的私有化报价，但遭基立福董事会拒绝，此举导致基立福股价大幅波动，该公司股价周三一度暴跌 14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223103a25f7452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223103a25f7452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2486312899","title":"医药股基立福西班牙股价跌幅扩大至10% 刷新日低","url":"https://stock-news.laohu8.com/highlight/detail?id=2486312899","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486312899?lang=zh_cn&edition=full","pubTime":"2024-11-28 22:27","pubTimestamp":1732804078,"startTime":"0","endTime":"0","summary":"医药股基立福西班牙股价跌幅扩大至10% 刷新日低","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411283254001344.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411283254001344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GRFS","BK1574","BK1515","BK1161","BK4139","09939"],"gpt_icon":0},{"id":"2486316123","title":"基立福(GRFS.US)积极与银行协商再融资 应对财务挑战与收购失败余波","url":"https://stock-news.laohu8.com/highlight/detail?id=2486316123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486316123?lang=zh_cn&edition=full","pubTime":"2024-11-28 21:15","pubTimestamp":1732799712,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，陷入财务困境的西班牙制药巨头基立福正积极与银行协商，旨在再融资其2025年到期的3.7亿欧元债券，并延长约14亿欧元的循环信贷额度，以此缓解投资者对其偿债能力的忧虑。基立福 家族拥有 基立福 约 35% 的股份。然而，阿比亚表示，目前，基立福 仍有信心能够让银行扭转局面，并称该公司已获得多家银行对再融资及扩大融资规模的积极回应，尽管仍有部分银行持保留意见，但公司仍在积极争取。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GRFS","162717","BK4139","161121"],"gpt_icon":0},{"id":"2486820392","title":"基立福股价重挫13.09% 市值跌6.74亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486820392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486820392?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:32","pubTimestamp":1732717921,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时32分，基立福股票出现异动，股价大幅跳水13.09%。截至发稿，该股报7.58美元/股，成交量33.6498万股，换手率0.05%，振幅1.32%。基立福股票所在的制药行业中，整体跌幅为0.35%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223201a259f1d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223201a259f1d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.grifols.com","stockEarnings":[{"period":"1week","weight":0.0859},{"period":"1month","weight":-0.1259},{"period":"3month","weight":-0.0261},{"period":"6month","weight":-0.1815},{"period":"1year","weight":0.076},{"period":"ytd","weight":-0.0484}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GRIFOLS, S.A.由Jose Antonio Grifols i Roig先生于1940年在西班牙巴塞罗那创建成立，公司是全球主要生物制药企业。公司业务涉及血浆系列产品的研发，生产和大范围销售。Grifols股份有限公司的商业活动包括原材料分类、生产各类型血浆提取产品以及将最终产出售并配送给保健品提供商。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.000926},{"month":2,"riseRate":0.571429,"avgChangeRate":0.01741},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.02113},{"month":4,"riseRate":0.5,"avgChangeRate":0.018384},{"month":5,"riseRate":0.461538,"avgChangeRate":0.012333},{"month":6,"riseRate":0.461538,"avgChangeRate":0.019747},{"month":7,"riseRate":0.642857,"avgChangeRate":0.021434},{"month":8,"riseRate":0.214286,"avgChangeRate":-0.037926},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.021077},{"month":10,"riseRate":0.5,"avgChangeRate":0.002945},{"month":11,"riseRate":0.5,"avgChangeRate":0.020752},{"month":12,"riseRate":0.714286,"avgChangeRate":0.031417}],"exchange":"NASDAQ","name":"基立福","nameEN":"Grifols SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基立福,GRFS,基立福股票,基立福股票老虎,基立福股票老虎国际,基立福行情,基立福股票行情,基立福股价,基立福股市,基立福股票价格,基立福股票交易,基立福股票购买,基立福股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}